15 Questions to Ask Before Starting GLP-1 Medications [2026]

Q: Can I take GLP-1 medications if I'm pregnant or planning to become pregnant?

No. GLP-1 medications should be discontinued at least **2 months before a planned pregnancy** (some providers recommend longer). Animal studies have shown adverse effects on fetal development. If you become pregnant while on a GLP-1, stop the medication and contact your prescriber immediately. The drugs have not been studied in pregnant humans, and the potential risks to the fetus are not fully understood.

Q: How long does it take for GLP-1 medications to start working?

Most patients notice reduced appetite within **1-2 weeks** of their first injection. Measurable weight loss typically begins within **4-8 weeks**. However, you'll start at a low dose and gradually increase, so the full therapeutic effect isn't reached until you hit your target dose — which can take **3-5 months** depending on the medication and your titration schedule.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. GLP-1 receptor agonists are prescription medications that should only be used under the supervision of a qualified healthcare provider. Always consult your doctor before starting, stopping, or changing any medication.

Affiliate Disclosure: Some links in this article may be affiliate links. We may earn a commission at no extra cost to you if you purchase through these links. This does not influence our editorial recommendations.

Walking into a doctor's office to ask about GLP-1 medications can feel overwhelming. You've seen the headlines. You've watched the before-and-after transformations on social media. Maybe a friend or coworker dropped 40 pounds on Ozempic and you want in.

But here's the thing most people skip: the conversation that should happen before the first injection.

GLP-1 receptor agonists are powerful medications. They work. The clinical data is strong. But they're not magic, and they're definitely not one-size-fits-all. The difference between a successful GLP-1 journey and a frustrating one often comes down to the questions you ask — or don't ask — before that first dose.

We talked to weight loss specialists, reviewed the latest 2026 research, and compiled the 15 questions that matter most. Whether you're considering Wegovy for weight loss, Mounjaro for diabetes management, or one of the newer dual and triple agonists like Retatrutide, these questions will help you make a genuinely informed decision.

If you're brand new to this entire medication class, start with our GLP-1 Medications for Beginners guide first, then come back here.

Section 1: Questions About Your Medical Eligibility

Before you think about which GLP-1 to choose or how much weight you'll lose, there's a more fundamental question: are you even a candidate?

Not everyone should take these medications. And some people have conditions that make specific GLP-1s riskier than others. Your prescriber should be screening for these — but you should be asking, too.

Question 1: "Do I have any conditions that make GLP-1 medications unsafe for me?"

This is the first question, full stop. Several medical conditions are contraindications — meaning the medication should not be prescribed at all.

The most well-known contraindication is a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2). MTC is a rare thyroid cancer. While a direct causative link between GLP-1 drugs and MTC hasn't been definitively proven in humans, the risk was observed in animal studies at clinically relevant doses during drug development. The FDA takes this seriously enough to include it as a boxed warning on every GLP-1 medication.

You should also flag any history of pancreatitis — either acute or chronic. Pancreatitis is a painful and potentially life-threatening inflammation of the pancreas, and GLP-1 medications can increase this risk.

If you have gastroparesis (slow stomach emptying), most GLP-1 medications will make it worse. These drugs work partly by slowing gastric emptying, which is great for appetite suppression but terrible if your stomach already doesn't empty properly.

And if you have diabetic retinopathy — damage to the blood vessels in your eyes from high blood sugar — you need to consult your eye doctor before starting semaglutide specifically. Clinical trials showed that rapidly improving blood sugar levels can paradoxically worsen existing eye damage in some patients.

Question 2: "Should I be screened for eating disorders before starting?"

This one gets overlooked constantly, and it shouldn't.

Current best practices recommend that all patients be screened for disordered eating behaviors before starting GLP-1 agonists. Screening tools include the SCOFF questionnaire (a quick five-question screen), the Eating Disorder Examination Questionnaire (more comprehensive), or the Binge Eating Scale.

Why does this matter? GLP-1 medications dramatically reduce appetite and change your relationship with food. For someone with an active eating disorder — particularly binge eating disorder, bulimia, or a restrictive pattern — adding a powerful appetite suppressant without proper psychological support can be dangerous. It can mask symptoms, create new disordered patterns, or trigger relapse.

A good prescriber will screen for this proactively. If yours doesn't bring it up, ask.

Question 3: "Am I the right age and health profile for these medications?"

Age matters more than most people realize. The FDA has approved certain GLP-1 medications for adolescents aged 12 and older, and research is ongoing for younger populations. On the other end of the spectrum, adults 65 and older face a different risk calculation.

In older adults, there's an established association between significant weight loss and all-cause mortality — especially in men who lose more than 10% of their body weight. The concern isn't the medication itself; it's that rapid weight loss in older adults can accelerate sarcopenia (muscle loss), reduce bone density, and increase fall risk.

For patients 65 and older, clinicians typically proceed with extra caution, often using lower doses, slower titration schedules, and incorporating resistance training and high-protein diets to preserve lean muscle mass.

Your prescriber should evaluate your complete health profile — kidney function, liver function, cardiovascular risk factors, current medications — before writing that prescription. If the evaluation feels rushed, that's a red flag.

Section 2: Questions About Which Medication Is Right for You

There are now multiple GLP-1 and GLP-1-adjacent medications on the market, and they're not interchangeable. Choosing the right one is a clinical decision that depends on your diagnosis, your goals, your insurance, and your tolerance for side effects.

Question 4: "What's the difference between a GLP-1 agonist and a dual or triple agonist — and which should I take?"

The GLP-1 medication landscape has gotten complicated fast. Here's the simplified breakdown:

Single GLP-1 receptor agonists — like semaglutide (Wegovy for weight loss, Ozempic for diabetes) and liraglutide (Saxenda) — target only the GLP-1 receptor. They reduce appetite, slow gastric emptying, and improve blood sugar control.

Dual GLP-1/GIP agonists — like tirzepatide (Mounjaro for diabetes, Zepbound for weight loss) — target two receptors. Clinical trials have shown tirzepatide produces greater average weight loss than semaglutide alone, with the SURMOUNT-1 trial demonstrating up to 22.5% body weight reduction at the highest dose over 72 weeks.

Triple agonists — like Retatrutide — target three receptors (GLP-1, GIP, and glucagon). Phase 2 trials showed weight loss of up to 24% at 48 weeks. These are still working through the FDA approval process in 2026 but represent the next frontier.

For a deep dive on the two most popular options, read our Semaglutide vs Tirzepatide: Head-to-Head [2026] comparison.

Ask your doctor which mechanism matches your clinical profile. Someone with type 2 diabetes might benefit more from tirzepatide's dual action. Someone primarily seeking weight loss without diabetes might do fine with semaglutide. And if you have significant metabolic syndrome, a triple agonist trial might be worth discussing.

Question 5: "Is there a clinical reason to choose one brand over another?"

Brand matters because formulation, dosing schedule, and approved indications differ.

Ozempic is approved for type 2 diabetes. Wegovy is approved for chronic weight management. Both contain semaglutide. But Wegovy goes to a higher maximum dose (2.4 mg vs. 2.0 mg) because weight loss often requires higher doses than blood sugar control.

Mounjaro is approved for type 2 diabetes. Zepbound is approved for weight loss. Both contain tirzepatide. Same drug, different indications, different pricing and insurance pathways.

The clinical reason to choose one over another often comes down to: What's your primary diagnosis? What has your insurance agreed to cover? And what side effect profile are you most willing to tolerate?

Question 6: "Should I consider a compounded version to save money?"

This is a loaded question in 2026, and you need to go in with eyes open.

Compounded GLP-1 medications — custom-mixed versions made by compounding pharmacies — cost dramatically less than brand-name versions. We're talking $150-400 per month versus $1,000-1,500+ for brand-name without insurance.

But the FDA has been clear: compounded medications are not FDA-approved, and their safety and efficacy have not been established for the same uses as their brand-name counterparts. The FDA has specifically warned that some compounded products involve dosing variability, added ingredients, or salt forms (such as semaglutide sodium or semaglutide acetate) that differ from FDA-approved medications. These variations may affect how the medication works in your body.

In 2025 and into 2026, the FDA issued multiple warnings about unapproved compounded GLP-1 products, and several compounding pharmacies faced enforcement actions.

Does that mean all compounded GLP-1s are dangerous? No. But it means you need to ask hard questions about where your compounded medication is sourced, whether the pharmacy is 503A or 503B registered, and what quality testing they perform.

For the full breakdown, read our Compounded vs Brand Name GLP-1 [2026] guide.

Section 3: Questions About Side Effects and What to Expect

GLP-1 medications come with side effects. That's not a deal-breaker — most medications do. But the side effects of GLP-1s are distinct, predictable, and manageable if you know what's coming. The problem is when people start these drugs expecting zero disruption to their daily life.

Question 7: "What side effects should I expect during the first month, and how do I manage them?"

Let's be straight about this: up to 50% of patients in phase 3 clinical trials experienced gastrointestinal side effects. The most common are nausea, vomiting, diarrhea, constipation, bloating, and abdominal pain.

The good news? These effects tend to be mild to moderate, are most pronounced during dose escalation (when your dose is being increased), and typically decrease over time as your body adjusts.

Here's what a good prescriber will tell you upfront:

Nausea is the most common complaint. Eating smaller meals, avoiding fatty or greasy foods, and eating slowly can help significantly. Some providers prescribe anti-nausea medication (like ondansetron) for the first few weeks.
Constipation affects roughly 20-25% of patients. Staying hydrated, eating fiber-rich foods, and using a gentle stool softener (like docusate) can prevent it from becoming a problem.
Diarrhea is less common but happens, especially in the first two weeks of a new dose. It usually resolves on its own.
"Sulfur burps" — that rotten-egg belching that patients describe on forums — is real and related to slowed gastric emptying. Smaller meals and avoiding carbonated drinks help.

The key phrase to remember: start low, go slow. Most side effects are dose-dependent, and a slow titration schedule (increasing your dose gradually over weeks or months) dramatically reduces their severity.

Question 8: "What are the serious but rare side effects I should watch for?"

Beyond the common GI symptoms, there are rarer but more serious adverse events you should know about:

Pancreatitis: Severe abdominal pain that radiates to your back, especially with nausea and vomiting, warrants an immediate trip to the emergency room. While the absolute risk is low, it's a medical emergency.

Gallbladder problems: GLP-1 medications are associated with an increased risk of gallstones and cholecystitis (gallbladder inflammation), particularly during rapid weight loss. Symptoms include sudden, intense pain in the upper right abdomen.

Kidney injury: Dehydration from nausea, vomiting, or diarrhea can stress the kidneys. Patients with pre-existing kidney disease need closer monitoring. Staying hydrated is non-negotiable.

Thyroid tumors: As mentioned earlier, the boxed warning about medullary thyroid carcinoma exists based on animal data. Report any lump or swelling in your neck, difficulty swallowing, or persistent hoarseness to your doctor immediately.

Mental health changes: Some patients report mood changes, increased anxiety, or depression. While large-scale clinical trials haven't established a definitive causal link, the FDA is actively monitoring post-market reports. If you notice significant mood changes after starting a GLP-1, tell your prescriber.

Ask your doctor specifically: "What symptoms should send me to the ER vs. what can I manage at home?" Get that clarity before you need it.

Question 9: "Will this medication interact with my current prescriptions?"

GLP-1 medications slow gastric emptying, which can affect the absorption of other oral medications. This is particularly relevant for:

Oral contraceptives: Slower absorption could theoretically reduce effectiveness. Some providers recommend using backup contraception during the first few months.
Oral diabetes medications: If you're already taking metformin, sulfonylureas, or insulin, your doses may need adjustment as the GLP-1 improves your blood sugar. The risk of hypoglycemia (dangerously low blood sugar) increases when combining GLP-1s with insulin or sulfonylureas.
Blood thinners: Warfarin absorption may be altered. INR monitoring should be increased when starting or adjusting a GLP-1.
Thyroid medications (levothyroxine): Absorption timing may shift. Your prescriber may recommend taking thyroid medication at a different time relative to your GLP-1 injection.

Bring a complete list of every medication, supplement, and over-the-counter product you take to your appointment. Not just prescriptions — everything.

Section 4: Questions About Realistic Expectations and Results

Here's where the social media hype meets clinical reality. The questions in this section will save you from disappointment, unrealistic timelines, and the frustration of comparing your results to someone else's Instagram transformation.

Question 10: "How much weight should I realistically expect to lose, and over what timeline?"

Let's look at what the clinical data actually shows:

Semaglutide 2.4 mg (Wegovy): The STEP 1 trial demonstrated an average weight loss of approximately 15% of body weight over 68 weeks. That means a 250-pound person could expect to lose roughly 37 pounds over about 16 months.

Tirzepatide (Zepbound): The SURMOUNT-1 trial showed average weight loss of 15-22.5% depending on dose, also over 72 weeks. At the highest dose (15 mg), the average person in the trial lost over 50 pounds.

Retatrutide: Phase 2 data showed up to 24% weight loss at 48 weeks, though phase 3 results are still pending in 2026.

But here's what the averages don't tell you: individual results vary enormously. Some people are "super responders" who lose 25-30% of their body weight. Others lose 5-8% and plateau. About 10-15% of patients in clinical trials are classified as "non-responders" who lose less than 5% of their body weight.

Factors that influence your results include genetics, starting weight, diet quality, physical activity level, sleep, stress, and medication adherence. The medication creates a biological advantage — it doesn't do the work for you.

Ask your prescriber: "Based on my specific profile, what's a reasonable weight loss target at 3 months, 6 months, and 12 months?" A good provider will give you a range, not a promise.

Question 11: "What happens to my weight if I stop taking the medication?"

This might be the most important question nobody asks.

The data here is sobering. The STEP 1 trial extension showed that participants who stopped semaglutide regained approximately two-thirds of their lost weight within one year of discontinuation. Metabolic improvements in blood pressure, blood sugar, and cholesterol also partially reversed.

This isn't a failure of willpower. It's biology. GLP-1 medications work by modifying the hormonal signals that drive hunger and satiety. When you remove the medication, those signals revert. Your body's "set point" — the weight your biology defends — hasn't necessarily changed.

This has major implications for how you think about GLP-1 treatment:

It's likely a long-term commitment. Many obesity medicine specialists now consider GLP-1 medications chronic therapy, similar to blood pressure or cholesterol medications.
Weight regain doesn't mean you failed. It means the underlying condition (obesity as a chronic disease) still exists.
An exit plan matters. If you do want to eventually stop, discuss a tapering strategy and a maintenance plan that includes behavioral interventions, dietary changes, and exercise.

Your prescriber should have a clear answer for: "What's the plan if I need to stop this medication — whether by choice, due to cost, or because of supply issues?"

Section 5: Questions About Cost, Insurance, and Access

The financial side of GLP-1 treatment is, for many people, the biggest barrier. And it's complicated. Prices vary wildly depending on your insurance, your diagnosis, which medication you're prescribed, and where you fill it.

Question 12: "What will this actually cost me per month, and does my insurance cover it?"

Here are the approximate list prices in 2026 (without insurance):

Medication	Monthly List Price
Wegovy	$1,300 - $1,400
Ozempic	$900 - $1,000
Zepbound	$1,000 - $1,100
Mounjaro	$1,000 - $1,100

Insurance coverage is a patchwork. Key factors:

Diagnosis matters. Most insurance plans are more likely to cover GLP-1s for type 2 diabetes than for weight loss alone. Some plans explicitly exclude anti-obesity medications.
Prior authorization is common. Your insurance may require documentation that you've tried diet and exercise, have a qualifying BMI (typically 30+ or 27+ with a comorbidity), and meet other criteria before approving coverage.
Employer plans vary wildly. Large employer plans increasingly cover weight loss medications, but smaller companies often don't. Check your specific formulary.
Medicare coverage has expanded in recent years but still has significant limitations. Medicare Part D now covers some GLP-1 medications for obesity in certain circumstances, a shift from the previous blanket exclusion.

Ask your prescriber's office: "Can you help with prior authorization? Do you have experience navigating insurance denials for this medication?" A practice that prescribes GLP-1s regularly will have staff who know the process.

Question 13: "Are there savings programs, coupons, or lower-cost alternatives?"

Yes — but the landscape shifts constantly. In 2026, here are the main cost-reduction strategies:

Manufacturer savings cards: Eli Lilly and Novo Nordisk both offer savings programs that can reduce out-of-pocket costs for commercially insured patients. These typically don't apply to government insurance (Medicare, Medicaid, Tricare).
Pharmacy shopping: Prices vary between pharmacies — sometimes by hundreds of dollars. Use tools like GoodRx to compare.
Telehealth platforms: Companies like Hims, Ro, and Found offer GLP-1 prescriptions bundled with coaching and monitoring, sometimes at lower total cost than traditional healthcare channels.
Compounded versions: As discussed in Question 6, compounded GLP-1s are significantly cheaper but come with important caveats about quality and regulation. See our Compounded vs Brand Name GLP-1 [2026] breakdown.
Generic semaglutide: With patents and regulatory landscapes evolving, generic options are beginning to enter the market in some regions. Ask your prescriber about availability.

Don't assume you can't afford it without checking every option. And don't assume the cheapest option is the safest.

Section 6: Questions About Lifestyle Changes and Support

A GLP-1 prescription is not a standalone weight loss plan. The medication creates a window of reduced appetite and improved metabolic function — but what you do inside that window determines your long-term results.

Question 14: "What dietary and exercise changes should I make while on a GLP-1?"

This question separates the patients who maintain their results from the ones who struggle. Here's what the evidence supports:

Protein is non-negotiable. GLP-1 medications cause weight loss, but not all of that weight is fat. Studies show that approximately 25-40% of weight lost can be lean muscle mass if you're not proactive about preserving it. To protect muscle:

Aim for 1.0-1.2 grams of protein per kilogram of body weight daily — some experts recommend up to 1.6 g/kg for active individuals
Prioritize protein at every meal, especially since your appetite is reduced and you're eating less overall
Consider a protein supplement if you're consistently falling short

Resistance training matters more than cardio. While any exercise is beneficial, strength training specifically helps preserve and build lean muscle mass during weight loss. The American College of Sports Medicine recommends at least 2-3 resistance training sessions per week for adults on GLP-1 medications.

Hydration is critical. GI side effects like nausea, vomiting, and diarrhea can cause dehydration, which in turn stresses your kidneys. Aim for at least 64 ounces of water daily — more if you're active or experiencing GI symptoms.

Meal composition shifts. Since you're eating less volume, every bite counts more:

Focus on nutrient-dense foods: lean proteins, vegetables, fruits, whole grains, healthy fats
Eat slowly — your stomach is emptying more slowly, and eating fast increases nausea
Avoid high-fat, greasy, and fried foods, which worsen GI symptoms
Limit alcohol, which can amplify nausea and has empty calories your reduced intake can't afford

Behavioral support helps. Patients who combine GLP-1 medication with structured behavioral counseling (cognitive behavioral therapy, dietitian support, or even app-based programs) consistently show better long-term outcomes than those on medication alone.

Ask your prescriber: "Do you offer or recommend a structured nutrition and exercise plan that pairs with this medication?" If the answer is just "eat less, move more," consider finding a provider who takes a more comprehensive approach.

Question 15: "What monitoring and follow-up should I expect while on this medication?"

Starting a GLP-1 isn't a "set it and forget it" situation. Responsible prescribing includes ongoing monitoring. Here's what that should look like:

In the first 3 months:

Follow-up visits every 2-4 weeks during dose titration
Monitoring for GI side effects and adjusting as needed
Blood work to check kidney function, liver function, blood sugar (if diabetic), and lipid panels
Weight and body composition tracking
Assessment of mental health and eating behaviors

Every 3-6 months ongoing:

Regular lab work (metabolic panel, A1C if diabetic, kidney function)
Weight and body composition assessment
Review of side effects and medication tolerance
Evaluation of whether the current dose is still appropriate
Discussion of long-term goals and potential dose adjustments

Annually:

Comprehensive metabolic panel
Thyroid function tests
Eye exam if you have diabetes (especially on semaglutide)
Bone density screening if you're at risk (older adults, postmenopausal women)
Reassessment of whether continued GLP-1 therapy is appropriate

If your prescriber writes a prescription and says "see you in a year" — that's not adequate care. GLP-1 treatment should include regular touchpoints, especially during the first six months.

Red flags that suggest you need closer follow-up or a medication change include: persistent vomiting, inability to eat adequate nutrition, signs of dehydration, significant mood changes, rapid or excessive weight loss (more than 1% per week consistently), or any new abdominal pain.

FAQ: Quick Answers to Common Pre-Start Questions

Can I take GLP-1 medications if I'm pregnant or planning to become pregnant?

No. GLP-1 medications should be discontinued at least 2 months before a planned pregnancy (some providers recommend longer). Animal studies have shown adverse effects on fetal development. If you become pregnant while on a GLP-1, stop the medication and contact your prescriber immediately. The drugs have not been studied in pregnant humans, and the potential risks to the fetus are not fully understood.

How long does it take for GLP-1 medications to start working?

Most patients notice reduced appetite within 1-2 weeks of their first injection. Measurable weight loss typically begins within 4-8 weeks. However, you'll start at a low dose and gradually increase, so the full therapeutic effect isn't reached until you hit your target dose — which can take 3-5 months depending on the medication and your titration schedule.

Can I drink alcohol while on a GLP-1 medication?

Technically yes, but with caution. Alcohol can worsen GI side effects, particularly nausea. Many patients also report that their alcohol tolerance decreases significantly on GLP-1 medications — one drink may feel like three. There's no absolute contraindication, but most providers recommend limiting intake and being aware that the effects of alcohol may be amplified.

Will I need to take this medication forever?

Not necessarily, but current evidence suggests that many patients will need long-term treatment to maintain weight loss. As discussed in Question 11, discontinuation studies show significant weight regain. Some patients successfully transition to lower maintenance doses. Others incorporate enough behavioral and dietary changes to sustain some of their weight loss after stopping. This is a conversation to have with your prescriber based on your individual response and goals.

What if I can't tolerate the side effects — are there alternatives?

Yes. If you can't tolerate one GLP-1 medication, you may tolerate another. Switching from semaglutide to tirzepatide (or vice versa) sometimes resolves persistent GI issues. Slower titration schedules help in many cases. Oral formulations (like oral semaglutide, brand name Rybelsus) have different side effect profiles than injectables. And there are non-GLP-1 weight loss medications — like phentermine-topiramate or naltrexone-bupropion — that work through different mechanisms entirely.